Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Effect of Ecopipam, a Selective Dopamine-1 Receptor Antagonist, on Tic Characteristics as Assessed by the YGTSS: Results from the Phase IIb (D1AMOND) Randomized, Double-blind, Placebo-controlled Clinical Trial in Tourette Syndrome

              Author:Gilbert, Donald   Karkanias, George   Munschauer, Frederick   Wanaski, Stephen   Cunniff, Timothy   

              Session Name:S30: Movement Disorders: Clinical Trials in Movement Disorders  

              Topic:Movement Disorders  

              Program Number:S30.009  

              Author Institution:Cincinnati Children's Hospital Med. Ctr., Cincinnati, OH  Emalex Biosciences, Inc., CHICAGO, IL  Paragon Biosciences, LLC, Chicago, IL  

              Safety and Tolerability of Ecopipam in Tourette Syndrome with Psychiatric Comorbidities

              Author:Gilbert, Donald   Cunniff, Timothy   Munschauer, Frederick   Karkanias, George   Atkinson, Sarah   Wanaski, Stephen   

              Session Name:P10: Movement Disorders: Tics and Other Hyperkinetic Movement Disorders  

              Topic:Movement Disorders  

              Program Number:P10.001  

              Author Institution:Cincinnati Children's Hospital Med. Ctr., Cincinnati, OH  Paragon Biosciences, LLC, Chicago, IL  Emalex Biosciences, Inc., CHICAGO, IL  

              Effects of Ecopipam on Growth and Development in Juvenile Rats

              Author:Wanaski, Stephen   Cunniff, Timothy   

              Session Name:P10: Movement Disorders: Tics and Other Hyperkinetic Movement Disorders  

              Topic:Movement Disorders  

              Program Number:P10.010  

              Author Institution:Paragon Biosciences, Chicago, IL  Paragon Biosciences, Northbrook, IL